cognitive impairment Clinical Trials and Research
Also known as: mild cognitive impairment, cognitive decline, memory loss, brain fog, thinking problems, neurocognitive disorder · ICD-10: R41.89
Cognitive impairment refers to difficulties with memory, thinking, or decision-making that are more significant than typical age-related changes. Clinical trial research is actively exploring new ways to understand its causes, improve diagnosis, and develop effective treatments. Find a Trial helps patients search for active studies.
Search cognitive impairment trials →
Common questions about cognitive impairment clinical trials
Who can participate in clinical trials for cognitive impairment?
Eligibility criteria vary greatly by study, often depending on the specific type and severity of cognitive impairment, age, and overall health. Researchers use these criteria to ensure patient safety and collect relevant data, as reported on ClinicalTrials.gov.
What are the different phases of clinical trials for cognitive impairment?
Clinical trials progress through phases 1 to 4. Early phases test safety and dosage, while later phases evaluate effectiveness and compare new interventions to existing ones, as detailed on ClinicalTrials.gov.
What are current research directions in cognitive impairment trials?
Current research, supported by sources like NIH RePORTER, focuses on identifying early biomarkers, developing drugs to target underlying disease processes, and exploring lifestyle interventions. Studies also investigate non-pharmacological approaches to manage symptoms.
What types of interventions are studied in cognitive impairment trials?
Trials investigate a range of interventions, including new medications, brain stimulation techniques, cognitive training programs, and dietary or exercise regimens. These studies aim to slow progression or improve cognitive function, according to ClinicalTrials.gov.
Are there specific biomarkers relevant to cognitive impairment research?
Yes, researchers often study biomarkers like amyloid and tau proteins in cerebrospinal fluid or through brain imaging (PET scans). Genetic markers and blood tests are also being investigated to aid early diagnosis and track disease progression, as seen on ClinicalTrials.gov.
Do clinical trials for cognitive impairment cost money to participate?
Generally, participants do not pay for study-related medical care or investigational treatments. Some trials may even cover travel expenses, though this varies. Details are always provided in the informed consent process, as noted on ClinicalTrials.gov.
What might prevent someone from joining a cognitive impairment trial?
Common exclusion criteria can include other serious medical conditions, certain medications that might interfere with the study drug, or a specific diagnosis not matching the trial's focus. These are designed to protect participants and ensure study integrity, according to ClinicalTrials.gov.
Can caregivers be involved in cognitive impairment clinical trials?
Many trials for cognitive impairment recognize the crucial role of caregivers. Some studies include caregivers in educational programs or ask for their input on patient well-being and daily functioning, as often outlined on ClinicalTrials.gov.
How to find a cognitive impairment trial that fits you
- Describe your cognitive impairment situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all cognitive impairment trials →